June Almenoff
Chief Tech/Sci/R&D Officer bei REDHILL BIOPHARMA LTD.
Vermögen: 7 444 $ am 31.03.2024
Profil
June Sherie Almenoff is currently an Independent Director at Tenax Therapeutics, Inc., an Independent Director at Avalo Therapeutics, Inc., and the Chief Medical Officer at RedHill Biopharma Ltd.
She previously held positions as the President, CEO, Director & Chief Marketing Officer at Furiex Pharmaceuticals, Inc. from 2010 to 2014, the Executive Chairman at RDD Pharma Ltd.
from 2015 to 2018, an Independent Non-Executive Director at TiGenix NV from 2016 to 2018, an Independent Director at Ohr Pharmaceutical, Inc. from 2013 to 2019, and a Director at Kurome Therapeutics, Inc. She is also a Member of the Infectious Diseases Society of America.
Dr. Almenoff worked at GlaxoSmithKline LLC as the Vice President-Clinical Safety Organization from 1997 to 2010.
She briefly served as the Chief Operating & Medical Officer at 9 Meters Biopharma, Inc. in 2018.
Dr. Almenoff received her undergraduate degree from Smith College and her doctorate from the Icahn School of Medicine at Mount Sinai.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.10.2023 | 13 175 ( 0,03% ) | 7 444 $ | 31.03.2024 | |
TENAX THERAPEUTICS, INC.
-.--% | 20.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von June Almenoff
| Unternehmen | Position | Beginn |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Chief Tech/Sci/R&D Officer | 28.05.2019 |
| TENAX THERAPEUTICS, INC. | Director/Board Member | 25.02.2021 |
| AVALO THERAPEUTICS, INC. | Director/Board Member | 10.11.2021 |
Ehemalige bekannte Positionen von June Almenoff
| Unternehmen | Position | Ende |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 01.12.2023 |
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Director/Board Member | 12.07.2019 |
| 9 METERS BIOPHARMA, INC. | Chief Operating Officer | 16.11.2018 |
| TIGENIX NV | Director/Board Member | 01.01.2018 |
| FURIEX PHARMACEUTICALS INC | Chief Executive Officer | 02.07.2014 |
Ausbildung von June Almenoff
| Smith College | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| REDHILL BIOPHARMA LTD. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Kurome Therapeutics, Inc.
 Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kurome Therapeutics, Inc. develops therapies that target cancer cells. The company was founded by Daniel Starczynowski and is headquartered in Cincinnati, OH. | Health Technology |
